Endocrine Today

💡 Children with type 1 #diabetes not using an automated insulin delivery system had a HbA1c of 8% at 2 years, but those who started using a system less than 6 months after diagnosis had an HbA1c of 7.1% @T1DExchange @WiscPediatrics @IDinChildren vist.ly/54d4e

📢 Data suggest #tirzepatide (Mounjaro/Zepbound, Eli Lilly) may improve cardiorenal health in patients with obesity who had TAVR, according to results presented at #SCAI2026 and in the journal of @SCAI vist.ly/54ahx

🚬 #ICYMI - The FDA for the first time authorized the marketing of four non-tobacco #vapes. The vapes possess age verification technology but some experts expressed concern that fruit flavoring may be appealing to youth. 🍇🍅 vist.ly/548vg

🚨 Just off embargo 🚨 Full data from TOGETHER-PsO, assessing Taltz ➕Zepbound for psoriasis with overweight/obesity. Data: 🔑 27.1% achieved clear skin with 10% weight loss 🔑 79.9% achieved PASI 75 with 5% weight loss 🔑 BP, lipids & HbA1c improvement vist.ly/54cf3

🗣️ Dr. Deborah Horn discusses the clinical implications of once-daily orforglipron among older adults with #obesity. Read our full coverage of this ATTAIN trial subanalysis presented at #ECO2026 ⬇️ @EASOobesity @GoHealio @EliLillyandCo vist.ly/54cpn

🗣️ “Ersodetug had a favorable safety profile, and there were signals that suggest a positive effect of ersodetug on glucose levels in trial participants.” Read more about the presentation on ersodetug from #PedsEndo2026 👇 @rezolutebio @ChildrensPhila vist.ly/54cgq

🍪 Adults with #obesity may be able to greatly reduce food noise by combining #GLP1 therapy with behavioral intervention, according to research presented at #ECO2026. @EASOobesity @PBRCNews @hanimecem @ww_us vist.ly/54bx7

📣 Hear from @ljaronne as he discusses the ATTAIN-MAINTAIN trial and how Foundayo may impact the #obesity treatment landscape. Read our full coverage ⬇️ @EliLillyandCo @EASOObesity #ECO2026 @GoHealio vist.ly/54b7a

💪 Beyond improvements in serum phosphate levels, the monoclonal antibody burosumab reduced pain and improved physical functioning for adults in a real-world setting. Learn more ⬇️ @CHEO @EndoMedia vist.ly/54b59

📢 “Our analysis of the pooled data of semaglutide in adults aged 65 years and older demonstrated that [it] was equally effective in weight loss in this age group than in the general population enrolled in the trials.” #ECO2026 @EASOobesity @GoHealio vist.ly/54828

🚨Take a look inside the #NationalQuarantineUnit where 16 Americans are isolated for up to 42 days after a #hantavirus outbreak on the #MVHondius. vist.ly/548mi

There is a disconnect between oncologists supporting #HormoneTherapy for #menopause symptoms related to #CervicalCancer and actual prescriptions. 🗨️ “There is no reason that this is not routine practice.” @deniskafab @RadoncUk @UKMarkey vist.ly/544c7

⚠️ #SCAI2026 ⚠️ Patients with #obesity who underwent transcatheter aortic valve replacement experienced lower risk for heart failure and acute kidney injury at 1 year if they took #tirzepatide than if they did not, @SCAI #TAVR #SCAI2026 vist.ly/546yb

🩺Prescribing physical activity is an easy way to make a major difference in patients’ lives, according to Liz Joy, MD, MPH, DABLM, FAMSSM, FACSM, a speaker at the annual @OMAsocial conference. #ObesityMedicineAssociation How is it done? 🔗Learn more: vist.ly/548ab

🤳 A 6-month text messaging program improved cardiovascular risk behaviors among patients with psoriasis. 💪 In the @JAMADerm study, participants sent regular motivational and education guidance via text message saw better lifestyle outcomes. vist.ly/5483j

📉 The percentage of weight loss that adults with #obesity maintained with 1 year of orforglipron therapy was 📌 74.7% after switching from Zepbound 📌 79.3% after switching from Wegovy @ljaronne @EliLillyandCo @EASOObesity #ECO2026 @GoHealio vist.ly/5476e

📉 The percentage of older adults with #obesity and type 2 #diabetes who achieved an HbA1c of 5.7% or lower at 72 weeks was: 📌 14.5% with orforglipron 36 mg 📌 22.6% with orforglipron 12 mg 📌 0.7% with placebo @EASOobesity @GoHealio @EliLillyandCo vist.ly/546uj

📉Earlier initiation of automated insulin delivery may benefit children and teens with type 1 #diabetes. Learn more about this analysis of data from @T1DExchange ⬇️ @WiscPediatrics @IDinChildren @GoHealio vist.ly/546s5

⬇️ Adults with #obesity who lose weight with tirzepatide 10 mg or 15 mg may be able to maintain most of that weight loss if they reduce their dose to 5 mg, researchers reported at #ECO2026 Read more 👇 @EliLillyandCo @EASOObesity @GoHealio vist.ly/546pb

🌙 People with chronic #insomnia had greater #sleep latency, lower sleep efficiency and greater intermittent wakefulness than good sleepers, said Dr. Devon A. Hansen of @wsu. Insomnia also was linked to greater night-to-night variability. 💤 vist.ly/53zxv